Articles about 'Cancer Research UK (CRUK)'

Replacing one sugary drink per day could cut risk of type 2 diabetes

01 May 2015

Drinking water or unsweetened tea or coffee in place of one sugary drink per day can reduce the risk of type 2 diabetes, according to research published today in the journal Diabetologia.

Color-enhancement show magnetic resonance image (MRI) of individual breast

Genetic screening could improve breast cancer prevention

09 April 2015

A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.

Childhood brain tumour expert to lead Cambridge Cancer Centre

26 March 2015

One of the world’s leading childhood brain tumour experts, Professor Richard Gilbertson, has been appointed as Li Ka Shing Chair of Oncology in Cambridge and Director of the Cambridge Cancer Centre. He will take up his appointment in August.

Fifteen new breast cancer genetic risk ‘hot-spots’ revealed

09 March 2015

Scientists have discovered 15 previously unknown genetic ‘hot-spots’ that can increase a woman’s risk of developing breast cancer, according to research published today in Nature Genetics.

Sleeping over eight hours a day associated with greater risk of stroke

25 February 2015

People who sleep for more than eight hours a day have an increased risk of stroke, according to a study by the ̽��ֱ�� of Cambridge – and this risk doubles for older people who persistently sleep longer than average. However, the researchers say it is unclear why this association exists and call for further research to explore the link.

An abdominal tumour (outlined in white) 'feeding on' carbon-13-labelled glucose (orange) provides a means of testing when cancer drugs are effective enough to affect the health of the tumour

Watching the death throes of tumours

25 February 2015

A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.

Order matters: sequence of genetic mutations determines how cancer behaves

11 February 2015

̽��ֱ��order in which genetic mutations are acquired determines how an individual cancer behaves, according to research from the ̽��ֱ�� of Cambridge, published today in the New England Journal of Medicine.

Celestial bodies

04 February 2015

Astronomy and oncology do not make obvious bedfellows, but the search for new stars and galaxies has surprising similarities with the search for cancerous cells. This has led to new ways of speeding up image analysis in cancer research.

First of new generation of cancer drugs granted European approval

18 December 2014

A new drug for ovarian cancer, developed by researchers at the ̽��ֱ�� of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. ̽��ֱ��drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Metastatic Breast Cancer in Pleural Fluid

Drugging the undruggable: discovery opens up possibility of slowing cancer spread

12 November 2014

A trawl through a library of more than 50,000 ‘small molecules’ has identified a potential candidate to inhibit the spread of cancer cells throughout the body. Reported today in the journal Nature Communications, the molecule targets a mechanism of tumour development that had previously been considered ‘undruggable’– in other words, extremely difficult, if not impossible, to target with a drug – and could open the door to further promising new candidates.

̽��ֱ��